Kiniksa Pharmaceuticals International, plc (KNSA)
Hamilton,
Total Compensation for Fiscal Year Ending in 2024: $7,129,792
| Salary | $899,371 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $1,679,160 |
| Value of Option Awards | $3,806,722 |
| Non-Equity Incentive Plan Compensation | $730,739 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $13,800 |
| Total | $7,129,792 |
Kiniksa Pharmaceuticals International, plc disclosed its CEO pay was
25
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
